{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:16:39Z","timestamp":1790201799850,"version":"4.1.0"},"reference-count":143,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiac amyloidosis is caused by the extracellular deposition of amyloid fibrils in the heart, involving not only the myocardium but also any cardiovascular structure. Indeed, this progressive infiltrative disease also involves the cardiac valves and, specifically, shows a high prevalence with aortic stenosis. Misfolded protein infiltration in the aortic valve leads to tissue damage resulting in the onset or worsening of valve stenosis. Transthyretin cardiac amyloidosis and aortic stenosis coexist in patients &amp;gt; 65 years in about 4\u201316% of cases, especially in those undergoing transcatheter aortic valve replacement. Diagnostic workup for cardiac amyloidosis in patients with aortic stenosis is based on a multi-parametric approach considering clinical assessment, electrocardiogram, haematologic tests, basic and advanced echocardiography, cardiac magnetic resonance, and technetium labelled cardiac scintigraphy like technetium-99\u2005m (99mTc)-pyrophosphate, 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid, and 99mTc-hydroxymethylene diphosphonate. However, a biopsy is the traditional gold standard for diagnosis. The prognosis of patients with coexisting cardiac amyloidosis and aortic stenosis is still under evaluation. The combination of these two pathologies worsens the prognosis. Regarding treatment, mortality is reduced in patients with cardiac amyloidosis and severe aortic stenosis after undergoing transcatheter aortic valve replacement. Further studies are needed to confirm these findings and to understand whether the diagnosis of cardiac amyloidosis could affect therapeutic strategies. The aim of this review is to critically expose the current state-of-art regarding the association of cardiac amyloidosis with aortic stenosis, from pathophysiology to treatment.<\/jats:p>","DOI":"10.1093\/ehjopen\/oead106","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T23:56:05Z","timestamp":1697068565000},"source":"Crossref","is-referenced-by-count":83,"title":["Cardiac amyloidosis and aortic stenosis: a state-of-the-art review"],"prefix":"10.1093","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2021-1660","authenticated-orcid":false,"given":"Vikash","family":"Jaiswal","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Research, Larkin Community Hospital , South Miami, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhor","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Medicine, King George\u2019s Medical University , Lucknow , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashita","family":"Khulbe","sequence":"additional","affiliation":[{"name":"Department of Medicine, King George\u2019s Medical University , Lucknow , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Hanif","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, SUNY Upstate Medical University , Syracuse, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2809-0154","authenticated-orcid":false,"given":"Helen","family":"Huang","sequence":"additional","affiliation":[{"name":"University of Medicine and Health Science, Royal College of Surgeons in Ireland , Dublin , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Hameed","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Florida State University, Sarasota Memorial Hospital , Sarasota, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0681-3825","authenticated-orcid":false,"given":"Abhigan Babu","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, M Abdur Rahim Medical College , Dinajpur , Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1418-7908","authenticated-orcid":false,"given":"Francesco","family":"Perone","sequence":"additional","affiliation":[{"name":"Cardiac Rehabilitation Unit, Rehabilitation Clinic \u2018Villa delle Magnolie\u2019 , 81020 Castel Morrone , Caserta, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charmy","family":"Parikh","sequence":"additional","affiliation":[{"name":"Carle BroMenn Medical Center , Normal, IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabas Ivan","family":"Gomez","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Research, Larkin Community Hospital , South Miami, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusum","family":"Paudel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kathmandu University School of Medical Science, Dhulikhel , Kathmandu 45209 , Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Zacks","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Icahn Medical School at Mount Sinai , NewYork 10128 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1369-5521","authenticated-orcid":false,"given":"Kendra J","family":"Grubb","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine , Atlanta, GA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"De Rosa","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Magna Graecia University , Catanzaro , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3378-1723","authenticated-orcid":false,"given":"Alessia","family":"Gimelli","sequence":"additional","affiliation":[{"name":"Department of Imaging, Fondazione Toscana\/CNR Gabriele Monasterio , Pisa 56124 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"2023122117363789700_oead106-B1","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","article-title":"Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis","volume":"135","author":"Maurer","year":"2017","journal-title":"Circulation"},{"key":"2023122117363789700_oead106-B2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.hjc.2019.10.004","article-title":"Transthyretin cardiac amyloidosis in aortic stenosis: prevalence, diagnostic challenges, and clinical implications","volume":"61","author":"Balciunaite","year":"2020","journal-title":"Hellenic J Cardiol"},{"key":"2023122117363789700_oead106-B3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jchf.2019.07.007","article-title":"A changing landscape of mortality for systemic light chain amyloidosis","volume":"7","author":"Barrett","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2023122117363789700_oead106-B4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0025-7125(03)00168-8","article-title":"Cardiac remodeling in systemic hypertension","volume":"88","author":"Kenchaiah","year":"2004","journal-title":"Med Clin North Am"},{"key":"2023122117363789700_oead106-B5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.38.1S5.V-61","article-title":"Aortic stenosis","volume":"38:","author":"Ross","year":"1968","journal-title":"Circulation"},{"key":"2023122117363789700_oead106-B6","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Casta\u00f1o","year":"2017","journal-title":"Eur Heart J"},{"key":"2023122117363789700_oead106-B7","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"2023122117363789700_oead106-B8","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/ejhf.2532","article-title":"Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies","volume":"24","author":"Aimo","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2023122117363789700_oead106-B9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.carpath.2009.04.005","article-title":"High prevalence of amyloid in 150 surgically removed heart valves\u2014a comparison of histological and clinical data reveals a correlation to atheroinflammatory conditions","volume":"19","author":"Kristen","year":"2010","journal-title":"Cardiovasc Pathol"},{"key":"2023122117363789700_oead106-B10","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","article-title":"Calcific aortic stenosis","volume":"60","author":"Dweck","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2023122117363789700_oead106-B11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.amjmed.2016.10.005","article-title":"Aortic stenosis: pathophysiology, diagnosis, and therapy","volume":"130","author":"Joseph","year":"2017","journal-title":"Am J Med"},{"key":"2023122117363789700_oead106-B12","doi-asserted-by":"crossref","first-page":"oeac011","DOI":"10.1093\/ehjopen\/oeac011","article-title":"Evaluation of the cardiac amyloidosis clinical pathway implementation: a real-world experience","volume":"2","author":"Brons","year":"2022","journal-title":"Eur Heart J Open"},{"key":"2023122117363789700_oead106-B13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.14740\/cr1436","article-title":"High prevalence of cardiac amyloidosis in clinically significant aortic stenosis: a meta-analysis","volume":"13","author":"Arshad","year":"2022","journal-title":"Cardiol Res"},{"key":"2023122117363789700_oead106-B14","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.3390\/jcm10184234","article-title":"Aortic valve stenosis and cardiac amyloidosis: a misleading association","volume":"10","author":"Bonelli","year":"2021","journal-title":"J Clin Med"},{"key":"2023122117363789700_oead106-B15","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023122117363789700_oead106-B16","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.jacc.2019.09.056","article-title":"Aortic stenosis and cardiac amyloidosis","volume":"74","author":"Ternacle","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023122117363789700_oead106-B17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jchf.2021.09.006","article-title":"Transthyretin V142I genetic variant and cardiac remodeling, injury, and heart failure risk in black adults","volume":"10","author":"Coniglio","year":"2022","journal-title":"JACC Heart Fail"},{"key":"2023122117363789700_oead106-B18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.amjcard.2006.08.031","article-title":"Racial differences among high-risk patients presenting with non\u2013ST-segment elevation acute coronary syndromes (results from the SYNERGY trial)","volume":"99","author":"Echols","year":"2007","journal-title":"Am J Cardiol"},{"key":"2023122117363789700_oead106-B19","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0735-1097(98)00045-X","article-title":"Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis","volume":"31","author":"Takemura","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"2023122117363789700_oead106-B20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/heartjnl-2016-310704","article-title":"Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response","volume":"103","author":"Grogan","year":"2017","journal-title":"Heart"},{"key":"2023122117363789700_oead106-B21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3390\/diagnostics12030627","article-title":"Multimodal imaging and biomarkers in cardiac amyloidosis","volume":"12","author":"Jung","year":"2022","journal-title":"Diagnostics"},{"key":"2023122117363789700_oead106-B22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ehf2.12203","article-title":"Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis: diagnostic utility of hs-cTnT in cardiac amyloidosis","volume":"5","author":"Takashio","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2023122117363789700_oead106-B23","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s11739-022-02958-2","article-title":"Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist","volume":"17","author":"Perfetto","year":"2022","journal-title":"Intern Emerg Med"},{"key":"2023122117363789700_oead106-B24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1536\/ihj.21-336","article-title":"Early detection of cardiac amyloidosis in transthyretin mutation carriers: case series and review of the literature","volume":"63","author":"Nagano","year":"2022","journal-title":"Int Heart J"},{"key":"2023122117363789700_oead106-B25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10439-020-02568-z","article-title":"Estimation of the acute myocardial infarction onset time based on time-course acquisitions","volume":"49","author":"Procopio","year":"2021","journal-title":"Ann Biomed Eng"},{"key":"2023122117363789700_oead106-B26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/14737167.2018.1512857","article-title":"Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays","volume":"18","author":"Veli\u010dkovi\u0107","year":"2018","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"2023122117363789700_oead106-B27","doi-asserted-by":"crossref","first-page":"106037","DOI":"10.1016\/j.cmpb.2021.106037","article-title":"CBRA: cardiac biomarkers release analyzer","volume":"204","author":"Procopio","year":"2021","journal-title":"Comput Methods Programs Biomed"},{"key":"2023122117363789700_oead106-B28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.12703\/r\/10-31","article-title":"Recent advances in the diagnosis and management of amyloid cardiomyopathy","volume":"10","author":"Nijst","year":"2021","journal-title":"Fac Rev"},{"key":"2023122117363789700_oead106-B29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11912-021-01028-8","article-title":"Updates in cardiac amyloidosis diagnosis and treatment","volume":"23","author":"Stern","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"2023122117363789700_oead106-B30","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1373\/clinchem.2004.046870","article-title":"Diagnostic performance of quantitative \u03ba and \u03bb free light chain assays in clinical practice","volume":"51","author":"Katzmann","year":"2005","journal-title":"Clin Chem"},{"key":"2023122117363789700_oead106-B31","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.amjcard.2014.07.026","article-title":"Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis","volume":"114","author":"Cyrille","year":"2014","journal-title":"Am J Cardiol"},{"key":"2023122117363789700_oead106-B32","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"key":"2023122117363789700_oead106-B33","doi-asserted-by":"crossref","first-page":"e006619","DOI":"10.1161\/CIRCHEARTFAILURE.119.006619","article-title":"Baseline ECG features and arrhythmic profile in transthyretin versus light chain cardiac amyloidosis","volume":"13","author":"Cappelli","year":"2020","journal-title":"Circ Heart Fail"},{"key":"2023122117363789700_oead106-B34","doi-asserted-by":"crossref","first-page":"e12967","DOI":"10.1111\/anec.12967","article-title":"Utility and pitfalls of the electrocardiogram in the evaluation of cardiac amyloidosis","volume":"27","author":"Ng","year":"2022","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2023122117363789700_oead106-B35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0002-9149(82)90270-3","article-title":"Amyloid cardiomyopathy: characterization by a distinctive voltage\/mass relation","volume":"49","author":"Carroll","year":"1982","journal-title":"Am J Cardiol"},{"key":"2023122117363789700_oead106-B36","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/ejhf.1756","article-title":"Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome","volume":"22","author":"Nitsche","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2023122117363789700_oead106-B37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2023122117363789700_oead106-B38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.amjcard.2004.10.028","article-title":"Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement","volume":"95","author":"Murtagh","year":"2005","journal-title":"Am J Cardiol"},{"key":"2023122117363789700_oead106-B39","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths","volume":"38","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Eur Heart J"},{"key":"2023122117363789700_oead106-B40","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/ehf2.13851","article-title":"Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis","volume":"9","author":"Papathanasiou","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2023122117363789700_oead106-B41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/13506129.2015.1028616","article-title":"Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role","volume":"22","author":"Longhi","year":"2015","journal-title":"Amyloid"},{"key":"2023122117363789700_oead106-B42","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/13506129.2019.1620724","article-title":"Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality","volume":"26","author":"Sanchis","year":"2019","journal-title":"Amyloid"},{"key":"2023122117363789700_oead106-B43","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12968-017-0415-x","article-title":"Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis","volume":"19","author":"Cavalcante","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2023122117363789700_oead106-B44","doi-asserted-by":"crossref","first-page":"e000289","DOI":"10.1136\/openhrt-2015-000289","article-title":"Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy","volume":"3","author":"Damy","year":"2016","journal-title":"Open Heart"},{"key":"2023122117363789700_oead106-B45","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s10554-023-02901-2","article-title":"Valve disease in cardiac amyloidosis: an echocardiographic score","volume":"39","author":"Aimo","year":"2023","journal-title":"Int J Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B46","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/echo.15497","article-title":"Current and novel echocardiographic assessment of left ventricular systolic function in aortic stenosis\u2014a comprehensive review","volume":"39","author":"Luke","year":"2022","journal-title":"Echocardiography"},{"key":"2023122117363789700_oead106-B47","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.mayocp.2014.01.013","article-title":"Cardiac amyloidosis without increased left ventricular wall thickness","volume":"89","author":"Lee","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"2023122117363789700_oead106-B48","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic resonance in transthyretin cardiac amyloidosis","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2023122117363789700_oead106-B49","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/ehjci\/jeac146","article-title":"Echocardiographic predictors of presence of cardiac amyloidosis in aortic stenosis","volume":"23","author":"Jaiswal","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B50","doi-asserted-by":"crossref","first-page":"e005066","DOI":"10.1161\/CIRCIMAGING.116.005066","article-title":"Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement","volume":"9","author":"Treibel","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B51","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ejhf.1974","article-title":"Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis","volume":"23","author":"Rosenblum","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2023122117363789700_oead106-B52","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cardfail.2018.07.001","article-title":"Myocardial contraction fraction by M-mode echocardiography is superior to ejection fraction in predicting mortality in transthyretin amyloidosis","volume":"24","author":"Rubin","year":"2018","journal-title":"J Card Fail"},{"key":"2023122117363789700_oead106-B53","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jcmg.2018.02.016","article-title":"Cardiac structural and functional consequences of amyloid deposition by cardiac magnetic resonance and echocardiography and their prognostic roles","volume":"12","author":"Knight","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B54","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jcmg.2018.08.040","article-title":"Assessment of subclinical left ventricular dysfunction in aortic stenosis","volume":"12","author":"Dahl","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B55","doi-asserted-by":"crossref","first-page":"e012257","DOI":"10.1161\/CIRCIMAGING.120.012257","article-title":"Myocardial contraction fraction for risk stratification in low-gradient aortic stenosis with preserved ejection fraction","volume":"14","author":"Rusinaru","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B56","first-page":"e013112","article-title":"Myocardial contraction fraction in low-gradient aortic stenosis: updating an old tool for a new application","author":"Gillam","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B57","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13506129.2014.994202","article-title":"The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis","volume":"22","author":"Tendler","year":"2015","journal-title":"Amyloid"},{"key":"2023122117363789700_oead106-B58","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcmg.2015.04.012","article-title":"Coexistence of degenerative aortic stenosis and wild-type transthyretin-related cardiac amyloidosis","volume":"9","author":"Longhi","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B59","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1093\/eurheartj\/ehw033","article-title":"Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?","volume":"37","author":"Galat","year":"2016","journal-title":"Eur Heart J"},{"key":"2023122117363789700_oead106-B60","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.amjcard.2007.11.047","article-title":"Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography","volume":"101","author":"Bellavia","year":"2008","journal-title":"Am J Cardiol"},{"key":"2023122117363789700_oead106-B61","first-page":"1442","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart Br Card Soc"},{"key":"2023122117363789700_oead106-B62","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.amjcard.2004.10.029","article-title":"Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis","volume":"95","author":"Ogiwara","year":"2005","journal-title":"Am J Cardiol"},{"key":"2023122117363789700_oead106-B63","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jcmg.2009.11.013","article-title":"Prognostic significance of strain Doppler imaging in light-chain amyloidosis","volume":"3","author":"Koyama","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B64","doi-asserted-by":"crossref","first-page":"ehaa946.1987","DOI":"10.1093\/ehjci\/ehaa946.1987","article-title":"Relative apical sparing in patients with severe aortic stenosis: prevalence and significance","volume":"41","author":"Abecasis","year":"2020","journal-title":"Eur Heart J"},{"key":"2023122117363789700_oead106-B65","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/jcm11030747","article-title":"Non-invasive myocardial work in patients with severe aortic stenosis","volume":"11","author":"De Rosa","year":"2022","journal-title":"J Clin Med"},{"key":"2023122117363789700_oead106-B66","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.echo.2019.11.018","article-title":"Left ventricular pressure-strain\u2013derived myocardial work at rest and during exercise in patients with cardiac amyloidosis","volume":"33","author":"Clemmensen","year":"2020","journal-title":"J Am Soc Echocardiogr"},{"key":"2023122117363789700_oead106-B67","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ehjci\/jeaa097","article-title":"Prognostic implications of left ventricular myocardial work indices in cardiac amyloidosis","volume":"22","author":"Clemmensen","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B68","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199211263272205","article-title":"Atrial systolic failure in primary amyloidosis","volume":"327","author":"Plehn","year":"1992","journal-title":"N Engl J Med"},{"key":"2023122117363789700_oead106-B69","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/01.CIR.83.3.808","article-title":"Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study","volume":"83","author":"Klein","year":"1991","journal-title":"Circulation"},{"key":"2023122117363789700_oead106-B70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcmg.2021.06.022","article-title":"Clinical importance of left atrial infiltration in cardiac transthyretin amyloidosis","volume":"15","author":"Bandera","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B71","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaccao.2020.10.010","article-title":"Left atrial mechanics associates with paroxysmal atrial fibrillation in light-chain amyloidosis following stem cell transplantation","volume":"2","author":"Lohrmann","year":"2020","journal-title":"JACC CardioOncology"},{"key":"2023122117363789700_oead106-B72","doi-asserted-by":"crossref","first-page":"oead040","DOI":"10.1093\/ehjopen\/oead040","article-title":"A novel echocardiographic risk score for light-chain amyloidosis","volume":"3","author":"Geenty","year":"2023","journal-title":"Eur Heart J Open"},{"key":"2023122117363789700_oead106-B73","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1253\/circj.CJ-16-0364","article-title":"Left atrial morphology, size and function in patients with transthyretin cardiac amyloidosis and primary hypertrophic cardiomyopathy\u2014comparative strain imaging study \u2013","volume":"80","author":"De Gregorio","year":"2016","journal-title":"Circ J"},{"key":"2023122117363789700_oead106-B74","first-page":"1128","article-title":"Left atrial structure and function in cardiac amyloidosis","volume":"18","author":"Nochioka","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B75","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3390\/biomedicines10081768","article-title":"Restrictive atrial dysfunction in cardiac amyloidosis: differences between immunoglobulin light chain and transthyretin cardiac amyloidosis patients","volume":"10","author":"Versteylen","year":"2022","journal-title":"Biomedicines"},{"key":"2023122117363789700_oead106-B76","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/ehjci\/jeaa415","article-title":"Determinants of left atrial reservoir and pump strain and use of atrial strain for evaluation of left ventricular filling pressure","volume":"23","author":"Inoue","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B77","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10554-020-01948-9","article-title":"Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease","volume":"37","author":"Rausch","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B78","doi-asserted-by":"crossref","first-page":"jeab289.045","DOI":"10.1093\/ehjci\/jeab289.045","article-title":"Multimodal imaging assessment of left atrial strain in cardiac amyloidosis and hypertrophic cardiomyopathies","volume":"23","author":"Lucas","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B79","first-page":"261","article-title":"Left atrial strain imaging by speckle tracking echocardiography: the supportive diagnostic value in cardiac amyloidosis and hypertrophic cardiomyopathy","volume":"10","author":"Monte","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"2023122117363789700_oead106-B80","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/hrt.74.5.541","article-title":"Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation","volume":"74","author":"Dubrey","year":"1995","journal-title":"Heart"},{"key":"2023122117363789700_oead106-B81","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/hrt.75.4.426-b","article-title":"Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation","volume":"75","author":"Stables","year":"1996","journal-title":"Heart"},{"key":"2023122117363789700_oead106-B82","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jcmg.2019.10.011","article-title":"Multiparametric echocardiography scores for the diagnosis of cardiac amyloidosis","volume":"13","author":"Boldrini","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B83","doi-asserted-by":"crossref","first-page":"658","DOI":"10.4070\/kcj.2020.0157","article-title":"CMR parametric mapping as a tool for myocardial tissue characterization","volume":"50","author":"Ferreira","year":"2020","journal-title":"Korean Circ J"},{"key":"2023122117363789700_oead106-B84","doi-asserted-by":"crossref","first-page":"e0263378","DOI":"10.1371\/journal.pone.0263378","article-title":"Prognostic value of cardiac magnetic resonance in patients with aortic stenosis: a systematic review and meta-analysis","volume":"17","author":"Zhang","year":"2022","journal-title":"PLOS ONE"},{"key":"2023122117363789700_oead106-B85","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12872-021-02086-3","article-title":"Native T1 mapping and extracellular volume fraction for differentiation of myocardial diseases from normal CMR controls in routine clinical practice","volume":"21","author":"Thongsongsang","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"2023122117363789700_oead106-B86","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis","volume":"6","author":"Karamitsos","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B87","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"2023122117363789700_oead106-B88","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-based differentiation of AL and ATTR cardiac amyloidosis","volume":"7","author":"Dungu","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B89","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/ehjci\/jeaa063","article-title":"Multimodality imaging in cardiac amyloidosis: a primer for cardiologists","volume":"21","author":"Jurcu\u0163","year":"2020","journal-title":"Eur Heart J\u2014Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B90","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","article-title":"Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis","volume":"3","author":"Syed","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B91","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/ehf2.12511","article-title":"Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis","volume":"6","author":"Brownrigg","year":"2019","journal-title":"ESC Heart Fail"},{"key":"2023122117363789700_oead106-B92","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2017.01.034","article-title":"Midwall fibrosis and 5-year outcome in moderate and severe aortic stenosis","volume":"69","author":"Vassiliou","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2023122117363789700_oead106-B93","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.acvd.2016.04.006","article-title":"Usefulness of 3-Tesla cardiac magnetic resonance imaging in the assessment of aortic stenosis severity in routine clinical practice","volume":"109","author":"Levy","year":"2016","journal-title":"Arch Cardiovasc Dis"},{"key":"2023122117363789700_oead106-B94","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and extracellular volume in transthyretin amyloidosis","volume":"12","author":"Martinez-Naharro","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B95","doi-asserted-by":"crossref","first-page":"101573","DOI":"10.1016\/j.cpcardiol.2022.101573","article-title":"Diagnostic and prognostic value of non-late gadolinium enhancement cardiac magnetic resonance parameters in cardiac amyloidosis","volume":"48","author":"Briasoulis","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"2023122117363789700_oead106-B96","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00392-020-01661-6","article-title":"Diagnostic value of the novel CMR parameter \u201cmyocardial transit-time\u201d (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy","volume":"110","author":"Chatzantonis","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"2023122117363789700_oead106-B97","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jcmg.2019.03.017","article-title":"Extracellular volume associates with outcomes more strongly than native or post-contrast myocardial T1","volume":"13","author":"Treibel","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B98","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2\u2014evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"2023122117363789700_oead106-B99","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99 m Tc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2023122117363789700_oead106-B100","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.jacc.2020.04.022","article-title":"Cardiac scintigraphy with technetium-99m-labeled bone-seeking tracers for suspected amyloidosis: JACC review topic of the week","volume":"75","author":"Hanna","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2023122117363789700_oead106-B101","first-page":"284","article-title":"Binding of serum amyloid P-component (SAP) by amyloid fibrils","volume":"38","author":"Pepys","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"2023122117363789700_oead106-B102","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.carpath.2016.07.001","article-title":"Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis","volume":"25","author":"Stats","year":"2016","journal-title":"Cardiovasc Pathol"},{"key":"2023122117363789700_oead106-B103","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1148\/radiology.148.1.6304810","article-title":"Amyloidosis of heart and liver: comparison of Tc-99 m pyrophosphate and Tc-99 m methylene diphosphonate for detection","volume":"148","author":"Lee","year":"1983","journal-title":"Radiology"},{"key":"2023122117363789700_oead106-B104","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s12350-017-1141-3","article-title":"Cardiac ATTR amyloid nuclear imaging\u2014not all bone scintigraphy radionuclide tracers are created equal","volume":"25","author":"Yang","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"2023122117363789700_oead106-B105","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12350-018-01552-4","article-title":"State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis","volume":"26","author":"Singh","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"2023122117363789700_oead106-B106","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","article-title":"Role of 99mTc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis","volume":"4","author":"Rapezzi","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B107","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99 m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B108","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"2023122117363789700_oead106-B109","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","article-title":"Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis","volume":"15","author":"Hutt","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2017.11.037","article-title":"Prevalence of cardiac amyloidosis in patients referred for transcatheter aortic valve replacement","volume":"71","author":"Scully","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023122117363789700_oead106-B111","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023122117363789700_oead106-B112","doi-asserted-by":"crossref","first-page":"e002954","DOI":"10.1161\/CIRCIMAGING.114.002954","article-title":"18F-Florbetapir binds specifically to myocardial light chain and transthyretin amyloid deposits: autoradiography study","volume":"8","author":"Park","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B113","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","article-title":"Cardiac amyloid imaging with 18F-florbetaben PET: a pilot study","volume":"57","author":"Law","year":"2016","journal-title":"J Nucl Med"},{"key":"2023122117363789700_oead106-B114","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00259-019-04290-y","article-title":"Detection of cardiac amyloidosis with 18F-florbetaben-PET\/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy","volume":"46","author":"Kircher","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023122117363789700_oead106-B115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","article-title":"In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET","volume":"54","author":"Antoni","year":"2013","journal-title":"J Nucl Med"},{"key":"2023122117363789700_oead106-B116","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","article-title":"11C-Pittsburgh B PET imaging in cardiac amyloidosis","volume":"8","author":"Lee","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B117","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s12149-019-01372-7","article-title":"Amyloid PET imaging in cardiac amyloidosis: a pilot study using 18F-flutemetamol positron emission tomography","volume":"33","author":"Dietemann","year":"2019","journal-title":"Ann Nucl Med"},{"key":"2023122117363789700_oead106-B118","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jcmg.2015.10.023","article-title":"Recognizing transthyretin cardiac amyloidosis in patients with aortic stenosis: impact on prognosis","volume":"9","author":"Sperry","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B119","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/eurheartj\/ehaa170","article-title":"Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation","volume":"41","author":"Scully","year":"2020","journal-title":"Eur Heart J"},{"key":"2023122117363789700_oead106-B120","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/eurheartj\/ehz905","article-title":"Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis","volume":"41","author":"Chacko","year":"2020","journal-title":"Eur Heart J"},{"key":"2023122117363789700_oead106-B121","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jcmg.2020.07.011","article-title":"Prognostic significance of cardiac amyloidosis in patients with aortic stenosis","volume":"14","author":"Ricci","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B122","doi-asserted-by":"crossref","first-page":"e014115","DOI":"10.1161\/CIRCIMAGING.122.014115","article-title":"Reverse remodeling following valve replacement in coexisting aortic stenosis and transthyretin cardiac amyloidosis","volume":"15","author":"Nitsche","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023122117363789700_oead106-B123","first-page":"67","article-title":"Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosis","volume":"108","author":"Patel","year":"2022","journal-title":"Heart Br Card Soc"},{"key":"2023122117363789700_oead106-B124","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2023122117363789700_oead106-B125","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"2023122117363789700_oead106-B126","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaccao.2021.06.006","article-title":"ATTR amyloidosis: current and emerging management strategies","volume":"3","author":"Griffin","year":"2021","journal-title":"JACC CardioOncol"},{"key":"2023122117363789700_oead106-B127","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/CIRCULATIONAHA.119.045093","article-title":"Cost-effectiveness of tafamidis therapy for transthyretin amyloid cardiomyopathy","volume":"141","author":"Kazi","year":"2020","journal-title":"Circulation"},{"key":"2023122117363789700_oead106-B128","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s10741-023-10312-7","article-title":"Acute advanced aortic stenosis","volume":"28:","author":"Avvedimento","year":"2023","journal-title":"Heart Fail Rev"},{"key":"2023122117363789700_oead106-B129","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2020.02.017","article-title":"Short-term effects of low-dose tolvaptan in acute decompensated heart failure patients with severe aortic stenosis: the LOHAS registry","volume":"305","author":"Watanabe","year":"2020","journal-title":"Int J Cardiol"},{"key":"2023122117363789700_oead106-B130","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1536\/ihj.16-226","article-title":"Successful treatment of congestive heart failure due to severe aortic valve stenosis with low dose tolvaptan in elderly patients","volume":"58","author":"Takasu","year":"2017","journal-title":"Int Heart J"},{"key":"2023122117363789700_oead106-B131","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10741-009-9153-y","article-title":"Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond","volume":"14","author":"Teerlink","year":"2009","journal-title":"Heart Fail Rev"},{"key":"2023122117363789700_oead106-B132","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/1755-5922.12132","article-title":"Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study","volume":"33","author":"Garc\u00eda-Gonz\u00e1lez","year":"2015","journal-title":"Cardiovasc Ther"},{"key":"2023122117363789700_oead106-B133","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/heartjnl-2016-311037","article-title":"Emergency treatment of decompensated aortic stenosis","volume":"104","author":"Bongiovanni","year":"2018","journal-title":"Heart"},{"key":"2023122117363789700_oead106-B134","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1161\/CIRCRESAHA.121.318187","article-title":"Pathophysiology and therapeutic approaches to cardiac amyloidosis","volume":"128","author":"Griffin","year":"2021","journal-title":"Circ Res"},{"key":"2023122117363789700_oead106-B135","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.healun.2003.08.027","article-title":"Cardiac transplantation for amyloid heart disease: the United Kingdom experience","volume":"23","author":"Dubrey","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"2023122117363789700_oead106-B136","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.healun.2008.05.016","article-title":"Autologous stem cell transplant after heart transplant for light chain (AL) amyloid cardiomyopathy","volume":"27","author":"Lacy","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"2023122117363789700_oead106-B137","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/TP.0b013e3181f10edb","article-title":"Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure","volume":"90","author":"Dey","year":"2010","journal-title":"Transplantation"},{"key":"2023122117363789700_oead106-B138","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.3390\/jcm9113392","article-title":"TAVR, SAVR and MI-AVR. Good things come to those who wait","volume":"9","author":"Piperata","year":"2020","journal-title":"J Clin Med"},{"key":"2023122117363789700_oead106-B139","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.carrev.2022.04.027","article-title":"Clinical outcome of TAVR vs SAVR in patients with cardiac amyloidosis","volume":"43","author":"Khan","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"2023122117363789700_oead106-B140","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1002\/ehf2.13876","article-title":"Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis","volume":"9","author":"Cannata","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2023122117363789700_oead106-B141","doi-asserted-by":"crossref","first-page":"101008","DOI":"10.1016\/j.ijcha.2022.101008","article-title":"Transcatheter aortic valve replacement in patients with aortic stenosis and cardiac amyloidosis","volume":"40","author":"Khawaja","year":"2022","journal-title":"IJC Heart Vasc"},{"key":"2023122117363789700_oead106-B142","doi-asserted-by":"crossref","first-page":"100255","DOI":"10.1016\/j.jacadv.2023.100255","article-title":"Outcomes of transcatheter aortic valve replacement in patients with coexisiting amyloidosis","volume":"2","author":"Elzeneini","year":"2023","journal-title":"JACC Adv"},{"key":"2023122117363789700_oead106-B143","doi-asserted-by":"crossref","first-page":"E128","DOI":"10.1093\/eurheartj\/suab107","article-title":"Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications","volume":"23","author":"Fabbri","year":"2021","journal-title":"Eur Heart J Suppl"}],"container-title":["European Heart Journal Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjopen\/advance-article-pdf\/doi\/10.1093\/ehjopen\/oead106\/52057481\/oead106.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/3\/6\/oead106\/54703484\/oead106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/3\/6\/oead106\/54703484\/oead106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T14:20:21Z","timestamp":1703168421000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjopen\/article\/doi\/10.1093\/ehjopen\/oead106\/7310830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":143,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjopen\/oead106","relation":{},"ISSN":["2752-4191"],"issn-type":[{"value":"2752-4191","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,10,12]]},"article-number":"oead106"}}